The Dietary Supplement Health and Education Act’s “bright line” between old and new ingredients does not illuminate regulation of the nutritional products market as Congress expected, says a former Senate staffer who helped write the bill.
DSHEA Sheds Little Light On Distinguishing Old From New Ingredients
Former Senate staffer Patricia Knight, who helped write DSHEA, says her “one regret” about the law passed in 1994 is “something we left out, how to prove, how to lock in what was on the market.” There “is just no way for the FDA to figure out what was on the market then,” she says.
More from United States
• By
Some advisory committee members said adding quantitative data on misuse, abuse, opioid use disorder and overdose to labeling would be helpful, but others worried the two epidemiological studies were not sufficiently generalizable to a broader population.
• By
Viatris joined Hikma and Amneal, in signing agreements for cash settlements that resolve allegations its practices fueled the US’ deadly opioid epidemic.
• By
Drugmakers are not expecting a big financial hit from tariffs for now, but a report commissioned by the industry trade association PhRMA suggests a potentially steep cost for pharma-sector tariffs.
• By
During its first quarter earnings call, Moderna avoided criticizing vaccine policy changes, but de-emphasized its flu/COVID-19 vaccine for those under age 50 and prioritized cancer programs.